Rationale and protocol of the Study Of diabetic Nephropathy with AtRasentan (SONAR) trial: A clinical trial design novel to diabetic nephropathy
出版年份 2018 全文链接
标题
Rationale and protocol of the Study Of diabetic Nephropathy with AtRasentan (SONAR) trial: A clinical trial design novel to diabetic nephropathy
作者
关键词
-
出版物
DIABETES OBESITY & METABOLISM
Volume 20, Issue 6, Pages 1369-1376
出版商
Wiley
发表日期
2018-02-06
DOI
10.1111/dom.13245
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Baseline characteristics and enrichment results from the SONAR trial
- (2018) Hiddo J.L. Heerspink et al. DIABETES OBESITY & METABOLISM
- Atrasentan Reduces Albuminuria by Restoring the Glomerular Endothelial Glycocalyx Barrier in Diabetic Nephropathy
- (2016) Margien G.S. Boels et al. DIABETES
- Is a reduction in albuminuria associated with renal and cardiovascular protection? Apost hocanalysis of the ALTITUDE trial
- (2016) H. J. L. Heerspink et al. DIABETES OBESITY & METABOLISM
- Unmet need in diabetic nephropathy: failed drugs or trials?
- (2016) Dick de Zeeuw et al. Lancet Diabetes & Endocrinology
- The renal protective effect of angiotensin receptor blockers depends on intra-individual response variation in multiple risk markers
- (2015) Bauke Schievink et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Predictors of Atrasentan-Associated Fluid Retention and Change in Albuminuria in Patients with Diabetic Nephropathy
- (2015) D. E. Kohan et al. Clinical Journal of the American Society of Nephrology
- Albuminuria Is an Appropriate Therapeutic Target in Patients with CKD: The Pro View
- (2015) H. J. Lambers Heerspink et al. Clinical Journal of the American Society of Nephrology
- ET and Diabetic Nephropathy: Preclinical and Clinical Studies
- (2015) Elena Gagliardini et al. SEMINARS IN NEPHROLOGY
- Prediction of the effect of atrasentan on renal and heart failure outcomes based on short-term changes in multiple risk markers
- (2015) Bauke Schievink et al. European Journal of Preventive Cardiology
- Predictors of Congestive Heart Failure after Treatment with an Endothelin Receptor Antagonist
- (2014) J. Hoekman et al. Clinical Journal of the American Society of Nephrology
- Drug-Induced Reduction in Albuminuria Is Associated with Subsequent Renoprotection: A Meta-Analysis
- (2014) H. J. Lambers Heerspink et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- The Endothelin Antagonist Atrasentan Lowers Residual Albuminuria in Patients with Type 2 Diabetic Nephropathy
- (2014) D. de Zeeuw et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Combined Angiotensin Inhibition for the Treatment of Diabetic Nephropathy
- (2013) Linda F. Fried et al. NEW ENGLAND JOURNAL OF MEDICINE
- Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease
- (2013) Dick de Zeeuw et al. NEW ENGLAND JOURNAL OF MEDICINE
- The effect of ramipril and telmisartan on serum potassium and its association with cardiovascular and renal events: Results from the ONTARGET trial
- (2013) Hiddo J Lambers Heerspink et al. European Journal of Preventive Cardiology
- Cardiorenal End Points in a Trial of Aliskiren for Type 2 Diabetes
- (2012) Hans-Henrik Parving et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sulodexide Fails to Demonstrate Renoprotection in Overt Type 2 Diabetic Nephropathy
- (2011) D. K. Packham et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Phase III and submission failures: 2007–2010
- (2011) John Arrowsmith NATURE REVIEWS DRUG DISCOVERY
- Increased serum potassium affects renal outcomes: a post hoc analysis of the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial
- (2010) Y. Miao et al. DIABETOLOGIA
- Avosentan for Overt Diabetic Nephropathy
- (2010) J. F.E. Mann et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Avosentan Reduces Albumin Excretion in Diabetics with Macroalbuminuria
- (2009) R. R. Wenzel et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease
- (2009) Marc A. Pfeffer et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started